REGULATION OF THE BETA(2)-ADRENERGIC RECEPTOR AND ITS MESSENGER-RNA IN THE RAT LUNG BY DEXAMETHASONE

被引:19
|
作者
MCGRAW, DW
CHAI, SE
HILLER, FC
CORNETT, LE
机构
[1] JOHN L MCCLELLAN MEM VET ADM MED CTR,DEPT MED,DIV PULM & CRIT CARE MED,LITTLE ROCK,AR 72205
[2] UNIV ARKANSAS MED SCI HOSP,DEPT PHYSIOL & BIOPHYS,LITTLE ROCK,AR 72205
关键词
BETA(2)-ADRENERGIC RECEPTORS; UP-REGULATION; LUNG; GLUCOCORTICOIDS;
D O I
10.3109/01902149509031757
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Glucocorticoids increase beta(2)-adrenergic responsiveness and receptor density in the lung, but the underlying mechanisms have not been clearly elucidated. To determine whether changes in beta(2)-adrenergic receptor gene expression are involved in vivo, we measured beta(2)-adrenergic receptor mRNA levels and beta(2)-adrenergic receptor density in lungs from Sprague-Dawley rats treated with a daily injection of dexamethasone (1 mg/kg subcutaneously) for 1, 3, or 7 days. Animals were sacrificed either 2 or 24 h after receiving the last injection. beta(2)-Adrenergic receptor mRNA levels were significantly (p < .05) elevated compared to saline-treated controls in the lungs of animals sacrificed 2 h after dexamethasone injection for 1 day (174 +/- 12%), 3 days (236 +/- 18%), and 7 days (220 +/- 11%). Receptor mRNA levels measured 24 h after dexamethasone injection did not differ significantly from the control group. Induction of beta(2)-adrenergic receptor mRNA by dexamethasone was transient, since no significant cumulative or sustained increase in receptor mRNA levels was observed during the study period. Treatment with dexamethasone increased beta(2)-adrenergic receptor density as expected, but no significant increase in receptor density was detected until 24 h after the third daily injection of dexamethasone, when levels reached 2045 +/- 150 fmol/mg protein compared to 1292 +/- 34 fmol/mg protein in the control group. Receptor density then remained at this elevated level through 7 days of treatment. These results show that dexamethasone up-regulates both the beta(2)-adrenergic receptor and its mRNA in vivo in the lung. The induction of beta(2)-adrenergic receptor mRNA levels indicates that glucocorticoids may regulate receptor density in the lung through modulation of gene expression. However, the difference between the time course of induction for the beta(2)-adrenergic receptor and its mRNA suggests that additional translational or post-translational mechanisms may also be involved.
引用
收藏
页码:535 / 546
页数:12
相关论文
共 50 条
  • [41] Early postnatal dexamethasone influences matrix metalloproteinase-2 and-9, and their tissue inhibitors in the developing rat lung
    Valencia, AM
    Beharry, KD
    Ang, JG
    Devarajan, K
    Van Woerkom, R
    Abrantes, M
    Nishihara, K
    Chang, E
    Waltzman, J
    Modanlou, HD
    PEDIATRIC PULMONOLOGY, 2003, 35 (06) : 456 - 462
  • [42] Induction of M2 Regulatory Macrophages through the β2-Adrenergic Receptor with Protection during Endotoxemia and Acute Lung Injury
    Grailer, Jamison J.
    Haggadone, Mikel D.
    Sarma, J. Vidya
    Zetoune, Firas S.
    Ward, Peter A.
    JOURNAL OF INNATE IMMUNITY, 2014, 6 (05) : 607 - 618
  • [43] Cell therapy rescues aging-induced beta-1 adrenergic receptor and GRK2 dysfunction in the coronary microcirculation
    Rowe, Gabrielle
    Tracy, Evan
    Beare, Jason E.
    LeBlanc, Amanda J.
    GEROSCIENCE, 2022, 44 (01) : 329 - 348
  • [44] GLUCOCORTICOID-INDUCED DOWN-REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA-1 IN ADULT-RAT LUNG FIBROBLASTS
    SHULL, S
    MEISLER, N
    ABSHER, M
    PHAN, S
    CUTRONEO, K
    LUNG, 1995, 173 (02) : 71 - 78
  • [45] Dexamethasone enhances the norepinephrine-induced ERK/MAPK intracellular pathway possibly via dysregulation of the α2-adrenergic receptor: Implications for antidepressant drug mechanism of action
    Yaniv, Shiri P.
    Lucki, Anat
    Klein, Ehud
    Ben-Shachar, Dorit
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2010, 89 (09) : 712 - 722
  • [46] P2Y2 receptor up-regulation induced by guanosine or UTP in rat brain cultured astrocytes
    Ballerini, R.
    Di Iorio, P.
    Caciagli, F.
    Rathbone, M. P.
    Jiang, S.
    Nargi, E.
    Buccella, S.
    Giuliani, P.
    D'Alimonte, I.
    Fischione, G.
    Masciulli, A.
    Romano, S.
    Ciccarelli, R.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2006, 19 (02) : 293 - 308
  • [47] Stress is a critical player in CYP3A, CYP2C, and CYP2D regulation: role of adrenergic receptor signaling pathways
    Daskalopoulos, Evangelos P.
    Malliou, Foteini
    Rentesi, Georgia
    Marselos, Marios
    Lang, Matti A.
    Konstandi, Maria
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2012, 303 (01): : E40 - E54
  • [48] Regulation of type-2 corticotropin-releasing hormone receptor mRNA in rat heart by glucocorticoids and urocortin
    Asaba, K
    Makino, S
    Nishiyama, M
    Hashimoto, K
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (04) : 493 - 497
  • [49] Regulation of corticotropin releasing hormone receptor type 1 messenger RNA level in Y-79 retinoblastoma cells: Potential implications for human stress response and immune/inflammatory reaction
    Vamvakopoulos, NC
    Sioutopoulou, TO
    Mamuris, Z
    Marcoulatos, P
    Avgerinos, PC
    MEDIATORS OF INFLAMMATION, 1996, 5 (05) : 328 - 333
  • [50] Dexamethasone rescues TGF-β1-mediated β2-adrenergic receptor dysfunction and attenuates phosphodiesterase 4D expression in human airway smooth muscle cells
    Elena Chung
    Christie A. Ojiaku
    Gaoyuan Cao
    Vishal Parikh
    Brian Deeney
    Shengjie Xu
    Serena Wang
    Reynold A. Panettieri
    Cynthia Koziol-White
    Respiratory Research, 21